Broad neutralization coverage of HIV by multiple highly potent antibodies View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2011-09-22

AUTHORS

Laura M. Walker, Michael Huber, Katie J. Doores, Emilia Falkowska, Robert Pejchal, Jean-Philippe Julien, Sheng-Kai Wang, Alejandra Ramos, Po-Ying Chan-Hui, Matthew Moyle, Jennifer L. Mitcham, Phillip W. Hammond, Ole A. Olsen, Pham Phung, Steven Fling, Chi-Huey Wong, Sanjay Phogat, Terri Wrin, Melissa D. Simek, , Wayne C. Koff, Ian A. Wilson, Dennis R. Burton, Pascal Poignard

ABSTRACT

Broadly neutralizing antibodies against highly variable viral pathogens are much sought after to treat or protect against global circulating viruses. Here we probed the neutralizing antibody repertoires of four human immunodeficiency virus (HIV)-infected donors with remarkably broad and potent neutralizing responses and rescued 17 new monoclonal antibodies that neutralize broadly across clades. Many of the new monoclonal antibodies are almost tenfold more potent than the recently described PG9, PG16 and VRC01 broadly neutralizing monoclonal antibodies and 100-fold more potent than the original prototype HIV broadly neutralizing monoclonal antibodies. The monoclonal antibodies largely recapitulate the neutralization breadth found in the corresponding donor serum and many recognize novel epitopes on envelope (Env) glycoprotein gp120, illuminating new targets for vaccine design. Analysis of neutralization by the full complement of anti-HIV broadly neutralizing monoclonal antibodies now available reveals that certain combinations of antibodies should offer markedly more favourable coverage of the enormous diversity of global circulating viruses than others and these combinations might be sought in active or passive immunization regimes. Overall, the isolation of multiple HIV broadly neutralizing monoclonal antibodies from several donors that, in aggregate, provide broad coverage at low concentrations is a highly positive indicator for the eventual design of an effective antibody-based HIV vaccine. More... »

PAGES

466-470

Journal

TITLE

Nature

ISSUE

7365

VOLUME

477

Related Patents

  • Broadly Neutralizing Antibody And Uses Thereof
  • High-Throughput Nucleotide Library Sequencing
  • Methods For Inducing An Immune Response Against Human Immunodeficiency Virus Infection In Subjects Undergoing Antiretroviral Treatment
  • Glycan Arrays For High Throughput Screening Of Viruses
  • Rm2 Antigens And Use Thereof
  • Cancer Markers And Methods Of Use Thereof
  • Compositions And Methods Relating To Universal Glycoforms For Enhanced Antibody Efficacy
  • Authentic Trimeric Hiv-1 Gp140 Envelope Glycoproteins Comprising A Long Linker And Tag
  • An Hiv-1 Gp120 Mini V3 Loop And Uses Thereof
  • Human Immunodeficiency Virus Neutralizing Antibodies
  • Broadly Neutralizing Monoclonal Antibodies Against Hiv-1 V1v2 Env Region
  • Broadly Neutralizing Monoclonal Antibodies Against Hiv-1 V1v2 Env Region
  • Influenza Hemagglutinin Proteins And Methods Of Thereof
  • Antibody Evolution Immunogens
  • Human Inkt Cell Activation Using Glycolipids With Altered Glycosyl Groups
  • Methods For Modifying Human Antibodies By Glycan Engineering
  • Method Of Purifying Authentic Trimeric Hiv-1 Gp140 Envelope Glycoproteins Comprising A Long Linker And Tag
  • Stabilized Mosaic Human Immunodeficiency Virus Type 1 (Hiv-1) Gp140 Envelope (Env) Trimers
  • Antibodies, Binding Fragments, And Methods Of Use
  • Biochemically Stabilized Hiv-1 Env Trimer Vaccine
  • Methods And Compositions For Inducing Protective Immunity Against Human Immunodeficiency Virus Infection
  • Methods For Inducing Protective Immunity Against Human Immunodeficiency Virus Infection
  • Hiv Vaccine Formulation
  • Glycan Arrays On Ptfe-Like Aluminum Coated Glass Slides And Related Methods
  • Designing A Soluble Full-Length Hiv-1 Gp41 Trimer
  • Antibody Drug Conjugates Binding To High-Mannose N-Glycan
  • Approach To Produce Hiv-1 Gp140 Envelope Protein Trimers
  • Human Immunodeficiency Virus (Hiv)-Neutralizing Antibodies
  • Stabilized Human Immunodeficiency Virus (Hiv) Clade C Envelope (Env) Trimer Vaccines And Methods Of Using Same
  • Cyclic Hiv-1 Env V3 Glycopeptide Immunogens
  • Antibody Evolution Immunogens
  • Bispecific Hiv-1 Neutralizing Antibodies
  • Human Immunodeficiency Virus Type 1 (Hiv-1) N-Terminal Deleted Gp120 Immunogens
  • Delivery Of Proteins Using Adeno-Associated Virus (Aav) Vectors
  • Multispecific Antibodies That Target Hiv Gp120 And Cd3
  • Biochemically Stabilized Hiv-1 Env Trimer Vaccine
  • Biochemically Stabilized Hiv-1 Env Trimer Vaccine
  • Broadly Neutralizing Human Immunodeficiency Virus Type 1 (Hiv-1) Gp120-Specific Monoclonal Antibody
  • Human Immunodeficiency Virus Neutralizing Antibodies
  • Human Inkt Cell Activation Using Glycolipids
  • Compositions And Methods For Treatment And Detection Of Cancers
  • Chimeric Antigen Receptors To Control Hiv Infection
  • Approach To Produce Hiv-1 Gp140 Envelope Protein Trimers
  • Hiv Antibody Compositions And Methods Of Use
  • Human Immunodeficiency Virus Therapies Utilizing N332-Glycan-Dependent Antibodies And A Reservoir Activator
  • Broadly-Neutralizing Anti-Hiv Antibodies
  • Broadly Neutralizing Antibody Directed Against Hiv-1 Gp140
  • Broadly Neutralizing Antibody And Uses Thereof
  • Human Immunodeficiency Virus Neutralizing Antibodies
  • Delivery Of Proteins Using Adeno-Associated Virus (Aav) Vectors
  • Materials And Methods For Producing Cleaved, Hiv-1 Envelope Glycoprotein Trimers
  • Human Immunodeficiency Virus (Hiv)-Neutralizing Antibodies
  • Broadly Neutralizing Human Immunodeficiency Virus Type 1 (Hiv-1) Gp120-Specific Monoclonal Antibody
  • Influenza Hemagglutinin Proteins And Methods Of Use Thereof
  • Glycan Conjugates And Methods Of Use Thereof
  • Single Cell Bar-Coding For Antibody Discovery
  • Methods For Inducing An Immune Response Against Human Immunodeficiency Virus Infection In Subjects Undergoing Antiretroviral Treatment
  • Methods For Modular Synthesis Of N-Glycans And Arrays Thereof
  • Biochemically Stabilized Hiv-1 Env Trimer Vaccine
  • Enhanced Anti-Influenza Agents Conjugated With Anti-Inflammatory Activity
  • Cell-Permeable Probes For Identification And Imaging Of Sialidases
  • Alkynyl Sugar Analogs For Labeling And Visualization Of Glycoconjugates In Cells
  • Antibody Therapies For Human Immunodeficiency Virus (Hiv)
  • Bispecific Hiv-1 Neutralizing Antibodies
  • Methods To Improve Vector Expression And Genetic Stability
  • Methods For Producing Antibodies
  • Trimer Stabilizing Hiv Envelope Protein Mutations
  • Single Cell Bar-Coding For Antibody Discovery
  • Methods For Identifying Broadly Neutralizing Antibodies Utilizing Recombinant Hiv-1 Envelope Glycoproteins Comprising Stabilizing Mutations
  • Method Of Purifying Authentic Trimeric Hiv-1 Envelope Glycoproteins Comprising A Long Linker And Tag
  • Human Immunodeficiency Virus (Hiv)-Neutralizing Antibodies
  • Anti-Her2 Glycoantibodies And Uses Thereof
  • Human Inkt Cell Activation Using Glycolipids With Altered Glycosyl Groups
  • Compositions Comprising Ch848 Envelopes And Uses Thereof
  • Synthetic Human Immunodeficiency Virus (Hiv) Envelope Antigen, Vectors, And Compositions Thereof
  • Hiv-1 Envelope Glycoprotein
  • B Cell Receptor Modification In B Cells
  • Compositions And Methods Relating To Universal Glycoforms For Enhanced Antibody Efficacy
  • Methods To Identify Prime And Boost Immunogens For Use In A B Cell Lineage-Based Vaccination Protocol
  • Broadly-Neutralizing Anti-Hiv Antibodies
  • Designing A Soluble Full-Length Hiv-1 Gp41 Trimer
  • Compositions And Methods For Treatment And Detection Of Cancers
  • Fret-Based Reagents And Methods For Identifying Anti-Hiv Compounds
  • Reactive Labelling Compounds And Uses Thereof
  • Glycan Conjugates And Use Thereof
  • Human Immunodeficiency Virus (Hiv)-Neutralizing Antibodies
  • Gp120 Immunogens And Methods Inducing Neutralizing Antibodies To Human Immunodeficiency Virus
  • Stabilized Human Immunodeficiency Virus (Hiv) Envelope (Env) Trimer Vaccines And Methods Of Using Same
  • Method Of Inducing An Immune Response Against Human Immunodeficiency Virus Comprising Administering Immunogenic Compositions Comprising Authentic Trimeric Hiv-1 Envelope Glycoproteins Containing A Long Linker And Tag
  • Authentic Trimeric Hiv-1 Envelope Glycoproteins Comprising A Long Linker And Tag
  • Hiv Antibody Compositions And Methods Of Use
  • Stabilized Env Proteins Of Hiv
  • Human Immunodeficiency Virus (Hiv)-Neutralizing Antibodies
  • Compositions And Methods For Treatment And Detection Of Cancers
  • Methods Of Single-Cell Barcoding And Sequencing
  • Human Inkt Cell Activation Using Glycolipids
  • Multispecific Antibodies That Target Hiv Gp120 And Cd3
  • Bispecific Hiv-1-Neutralizing Antibodies
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/nature10373

    DOI

    http://dx.doi.org/10.1038/nature10373

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1044845665

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/21849977


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Immunology", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1108", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical Microbiology", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "AIDS Vaccines", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antibodies, Monoclonal", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antibodies, Neutralizing", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Line", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Epitope Mapping", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Epitopes", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Glycoproteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Glycosylation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "HEK293 Cells", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "HIV", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "HIV Antibodies", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "HIV Infections", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Human Immunodeficiency Virus Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immune Sera", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Molecular Sequence Data", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neutralization Tests", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Immunology and Microbial Science and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California 92037, USA", 
              "id": "http://www.grid.ac/institutes/grid.214007.0", 
              "name": [
                "Department of Immunology and Microbial Science and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California 92037, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Walker", 
            "givenName": "Laura M.", 
            "id": "sg:person.01342666706.29", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342666706.29"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts 02129, USA", 
              "id": "http://www.grid.ac/institutes/grid.461656.6", 
              "name": [
                "Department of Immunology and Microbial Science and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California 92037, USA", 
                "Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts 02129, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Huber", 
            "givenName": "Michael", 
            "id": "sg:person.01014667730.93", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014667730.93"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts 02129, USA", 
              "id": "http://www.grid.ac/institutes/grid.461656.6", 
              "name": [
                "Department of Immunology and Microbial Science and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California 92037, USA", 
                "Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts 02129, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Doores", 
            "givenName": "Katie J.", 
            "id": "sg:person.015354421747.51", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015354421747.51"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts 02129, USA", 
              "id": "http://www.grid.ac/institutes/grid.461656.6", 
              "name": [
                "Department of Immunology and Microbial Science and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California 92037, USA", 
                "Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts 02129, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Falkowska", 
            "givenName": "Emilia", 
            "id": "sg:person.01314314746.53", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01314314746.53"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Molecular Biology, Skaggs Institute for Chemical Biology, and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California 92037, USA", 
              "id": "http://www.grid.ac/institutes/grid.214007.0", 
              "name": [
                "Department of Molecular Biology, Skaggs Institute for Chemical Biology, and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California 92037, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Pejchal", 
            "givenName": "Robert", 
            "id": "sg:person.01310030246.94", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310030246.94"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Molecular Biology, Skaggs Institute for Chemical Biology, and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California 92037, USA", 
              "id": "http://www.grid.ac/institutes/grid.214007.0", 
              "name": [
                "Department of Molecular Biology, Skaggs Institute for Chemical Biology, and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California 92037, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Julien", 
            "givenName": "Jean-Philippe", 
            "id": "sg:person.01070170150.53", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070170150.53"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Chemistry, The Scripps Research Institute, La Jolla, California 92037, USA", 
              "id": "http://www.grid.ac/institutes/grid.214007.0", 
              "name": [
                "Department of Chemistry, The Scripps Research Institute, La Jolla, California 92037, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wang", 
            "givenName": "Sheng-Kai", 
            "id": "sg:person.01235524034.35", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235524034.35"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Immunology and Microbial Science and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California 92037, USA", 
              "id": "http://www.grid.ac/institutes/grid.214007.0", 
              "name": [
                "Department of Immunology and Microbial Science and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California 92037, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ramos", 
            "givenName": "Alejandra", 
            "id": "sg:person.01232301406.99", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01232301406.99"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Theraclone Sciences, Inc., Seattle, Washington 98104, USA", 
              "id": "http://www.grid.ac/institutes/grid.488352.0", 
              "name": [
                "Theraclone Sciences, Inc., Seattle, Washington 98104, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Chan-Hui", 
            "givenName": "Po-Ying", 
            "id": "sg:person.01035513046.15", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01035513046.15"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Theraclone Sciences, Inc., Seattle, Washington 98104, USA", 
              "id": "http://www.grid.ac/institutes/grid.488352.0", 
              "name": [
                "Theraclone Sciences, Inc., Seattle, Washington 98104, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Moyle", 
            "givenName": "Matthew", 
            "id": "sg:person.01347446637.44", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01347446637.44"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Theraclone Sciences, Inc., Seattle, Washington 98104, USA", 
              "id": "http://www.grid.ac/institutes/grid.488352.0", 
              "name": [
                "Theraclone Sciences, Inc., Seattle, Washington 98104, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Mitcham", 
            "givenName": "Jennifer L.", 
            "id": "sg:person.0620201437.14", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620201437.14"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Theraclone Sciences, Inc., Seattle, Washington 98104, USA", 
              "id": "http://www.grid.ac/institutes/grid.488352.0", 
              "name": [
                "Theraclone Sciences, Inc., Seattle, Washington 98104, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hammond", 
            "givenName": "Phillip W.", 
            "id": "sg:person.01115763106.81", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01115763106.81"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Theraclone Sciences, Inc., Seattle, Washington 98104, USA", 
              "id": "http://www.grid.ac/institutes/grid.488352.0", 
              "name": [
                "Theraclone Sciences, Inc., Seattle, Washington 98104, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Olsen", 
            "givenName": "Ole A.", 
            "id": "sg:person.01113130537.77", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01113130537.77"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Monogram Biosciences, Inc., South San Francisco, California 94080, USA", 
              "id": "http://www.grid.ac/institutes/grid.419316.8", 
              "name": [
                "Monogram Biosciences, Inc., South San Francisco, California 94080, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Phung", 
            "givenName": "Pham", 
            "id": "sg:person.0600752306.32", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600752306.32"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "International AIDS Vaccine Initiative, New York, New York 10038, USA", 
              "id": "http://www.grid.ac/institutes/grid.420368.b", 
              "name": [
                "International AIDS Vaccine Initiative, New York, New York 10038, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Fling", 
            "givenName": "Steven", 
            "id": "sg:person.01132352061.18", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132352061.18"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Chemistry, The Scripps Research Institute, La Jolla, California 92037, USA", 
              "id": "http://www.grid.ac/institutes/grid.214007.0", 
              "name": [
                "Department of Chemistry, The Scripps Research Institute, La Jolla, California 92037, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wong", 
            "givenName": "Chi-Huey", 
            "id": "sg:person.012145621207.41", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012145621207.41"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "International AIDS Vaccine Initiative, New York, New York 10038, USA", 
              "id": "http://www.grid.ac/institutes/grid.420368.b", 
              "name": [
                "International AIDS Vaccine Initiative, New York, New York 10038, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Phogat", 
            "givenName": "Sanjay", 
            "id": "sg:person.010557764454.41", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010557764454.41"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Monogram Biosciences, Inc., South San Francisco, California 94080, USA", 
              "id": "http://www.grid.ac/institutes/grid.419316.8", 
              "name": [
                "Monogram Biosciences, Inc., South San Francisco, California 94080, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wrin", 
            "givenName": "Terri", 
            "id": "sg:person.01044473444.91", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044473444.91"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "International AIDS Vaccine Initiative, New York, New York 10038, USA", 
              "id": "http://www.grid.ac/institutes/grid.420368.b", 
              "name": [
                "International AIDS Vaccine Initiative, New York, New York 10038, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Simek", 
            "givenName": "Melissa D.", 
            "id": "sg:person.0762674771.14", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0762674771.14"
            ], 
            "type": "Person"
          }, 
          {}, 
          {
            "affiliation": {
              "alternateName": "International AIDS Vaccine Initiative, New York, New York 10038, USA", 
              "id": "http://www.grid.ac/institutes/grid.420368.b", 
              "name": [
                "International AIDS Vaccine Initiative, New York, New York 10038, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Koff", 
            "givenName": "Wayne C.", 
            "id": "sg:person.0623034006.06", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0623034006.06"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Molecular Biology, Skaggs Institute for Chemical Biology, and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California 92037, USA", 
              "id": "http://www.grid.ac/institutes/grid.214007.0", 
              "name": [
                "Department of Molecular Biology, Skaggs Institute for Chemical Biology, and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California 92037, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wilson", 
            "givenName": "Ian A.", 
            "id": "sg:person.013704442772.59", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013704442772.59"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts 02129, USA", 
              "id": "http://www.grid.ac/institutes/grid.461656.6", 
              "name": [
                "Department of Immunology and Microbial Science and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California 92037, USA", 
                "Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts 02129, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Burton", 
            "givenName": "Dennis R.", 
            "id": "sg:person.01215352065.27", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215352065.27"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "International AIDS Vaccine Initiative, New York, New York 10038, USA", 
              "id": "http://www.grid.ac/institutes/grid.420368.b", 
              "name": [
                "Department of Immunology and Microbial Science and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California 92037, USA", 
                "International AIDS Vaccine Initiative, New York, New York 10038, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Poignard", 
            "givenName": "Pascal", 
            "id": "sg:person.01067201057.73", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067201057.73"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/nature07352", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041549961", 
              "https://doi.org/10.1038/nature07352"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature09385", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033805072", 
              "https://doi.org/10.1038/nature09385"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nm.1974", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021736242", 
              "https://doi.org/10.1038/nm.1974"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrmicro1819", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031201834", 
              "https://doi.org/10.1038/nrmicro1819"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ni.1746", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038843818", 
              "https://doi.org/10.1038/ni.1746"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nm.1949", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025533402", 
              "https://doi.org/10.1038/nm.1949"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2011-09-22", 
        "datePublishedReg": "2011-09-22", 
        "description": "Broadly neutralizing antibodies against highly variable viral pathogens are much sought after to treat or protect against global circulating viruses. Here we probed the neutralizing antibody repertoires of four human immunodeficiency virus (HIV)-infected donors with remarkably broad and potent neutralizing responses and rescued 17 new monoclonal antibodies that neutralize broadly across clades. Many of the new monoclonal antibodies are almost tenfold more potent than the recently described PG9, PG16 and VRC01 broadly neutralizing monoclonal antibodies and 100-fold more potent than the original prototype HIV broadly neutralizing monoclonal antibodies. The monoclonal antibodies largely recapitulate the neutralization breadth found in the corresponding donor serum and many recognize novel epitopes on envelope (Env) glycoprotein gp120, illuminating new targets for vaccine design. Analysis of neutralization by the full complement of anti-HIV broadly neutralizing monoclonal antibodies now available reveals that certain combinations of antibodies should offer markedly more favourable coverage of the enormous diversity of global circulating viruses than others and these combinations might be sought in active or passive immunization regimes. Overall, the isolation of multiple HIV broadly neutralizing monoclonal antibodies from several donors that, in aggregate, provide broad coverage at low concentrations is a highly positive indicator for the eventual design of an effective antibody-based HIV vaccine.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/nature10373", 
        "inLanguage": "en", 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.2458801", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2452571", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1018957", 
            "issn": [
              "0028-0836", 
              "1476-4687"
            ], 
            "name": "Nature", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "7365", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "477"
          }
        ], 
        "keywords": [
          "new monoclonal antibody", 
          "monoclonal antibodies", 
          "antibody-based HIV vaccine", 
          "variable viral pathogens", 
          "human immunodeficiency virus", 
          "envelope glycoprotein gp120", 
          "multiple HIV", 
          "neutralization coverage", 
          "HIV vaccine", 
          "immunodeficiency virus", 
          "donor sera", 
          "neutralization breadth", 
          "novel epitopes", 
          "immunization regimes", 
          "potent antibodies", 
          "HIV", 
          "glycoprotein gp120", 
          "vaccine design", 
          "antibodies", 
          "new targets", 
          "viral pathogens", 
          "virus", 
          "VRC01", 
          "gp120", 
          "vaccine", 
          "donors", 
          "low concentrations", 
          "serum", 
          "epitopes", 
          "PG16", 
          "full complement", 
          "available reveals", 
          "positive indicators", 
          "PG9", 
          "pathogens", 
          "broad coverage", 
          "neutralization", 
          "response", 
          "combination", 
          "target", 
          "coverage", 
          "complement", 
          "concentration", 
          "indicators", 
          "isolation", 
          "certain combinations", 
          "analysis", 
          "enormous diversity", 
          "eventual design", 
          "design", 
          "breadth", 
          "favorable coverage", 
          "reveals", 
          "aggregates", 
          "diversity", 
          "clade", 
          "regime", 
          "original prototype HIV", 
          "prototype HIV", 
          "corresponding donor serum", 
          "Analysis of neutralization", 
          "passive immunization regimes", 
          "effective antibody-based HIV vaccine", 
          "Broad neutralization coverage"
        ], 
        "name": "Broad neutralization coverage of HIV by multiple highly potent antibodies", 
        "pagination": "466-470", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1044845665"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/nature10373"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "21849977"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/nature10373", 
          "https://app.dimensions.ai/details/publication/pub.1044845665"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2021-12-01T19:24", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_531.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/nature10373"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/nature10373'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/nature10373'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/nature10373'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/nature10373'


     

    This table displays all metadata directly associated to this object as RDF triples.

    400 TRIPLES      22 PREDICATES      114 URIs      99 LITERALS      24 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/nature10373 schema:about N0a1525c790e6456fb71063ff4774d8f1
    2 N0c05c99457184c5fb3b365fffa9bbe77
    3 N18038565f028408ca74c4c43c1fdf795
    4 N31788b8fdb0e488a8dc1f0fb4d422c27
    5 N3878766ff1c541f188ca3174ae23971b
    6 N4b50f2845bda4328abdbc40bf0cb40a3
    7 N605b6a4dbe054dfea917216c09240edd
    8 N6aae999d2b8142618367f22733c6fab0
    9 N83a201b156b34cb191baf776317d906f
    10 N8a4d24d1adab4897a5a1265ef0f4f281
    11 N8cfddcb1fcf847c5a2bcdfcbceed47ba
    12 N8d99ccf520784913b2df832d3b1f9912
    13 Nae04613a0770442ab2606bc7e2f1f127
    14 Nbb39f983dbae47c0b59f1b53f93a04bd
    15 Nc41c6e87fa4a471cb0b8c7c688ac0177
    16 Nf734a8a660db47a099ba823fe8e1c3f2
    17 Nff5701f865fa4230b51a57417c7f486e
    18 anzsrc-for:11
    19 anzsrc-for:1107
    20 anzsrc-for:1108
    21 schema:author Ne6d23735271c4c4ea42c9fac6b8190d0
    22 schema:citation sg:pub.10.1038/nature07352
    23 sg:pub.10.1038/nature09385
    24 sg:pub.10.1038/ni.1746
    25 sg:pub.10.1038/nm.1949
    26 sg:pub.10.1038/nm.1974
    27 sg:pub.10.1038/nrmicro1819
    28 schema:datePublished 2011-09-22
    29 schema:datePublishedReg 2011-09-22
    30 schema:description Broadly neutralizing antibodies against highly variable viral pathogens are much sought after to treat or protect against global circulating viruses. Here we probed the neutralizing antibody repertoires of four human immunodeficiency virus (HIV)-infected donors with remarkably broad and potent neutralizing responses and rescued 17 new monoclonal antibodies that neutralize broadly across clades. Many of the new monoclonal antibodies are almost tenfold more potent than the recently described PG9, PG16 and VRC01 broadly neutralizing monoclonal antibodies and 100-fold more potent than the original prototype HIV broadly neutralizing monoclonal antibodies. The monoclonal antibodies largely recapitulate the neutralization breadth found in the corresponding donor serum and many recognize novel epitopes on envelope (Env) glycoprotein gp120, illuminating new targets for vaccine design. Analysis of neutralization by the full complement of anti-HIV broadly neutralizing monoclonal antibodies now available reveals that certain combinations of antibodies should offer markedly more favourable coverage of the enormous diversity of global circulating viruses than others and these combinations might be sought in active or passive immunization regimes. Overall, the isolation of multiple HIV broadly neutralizing monoclonal antibodies from several donors that, in aggregate, provide broad coverage at low concentrations is a highly positive indicator for the eventual design of an effective antibody-based HIV vaccine.
    31 schema:genre article
    32 schema:inLanguage en
    33 schema:isAccessibleForFree true
    34 schema:isPartOf N8b897360bca748bdbeef4870f61da36e
    35 Nfbf44a9d3b5f4fafb7234edd6bf17ad5
    36 sg:journal.1018957
    37 schema:keywords Analysis of neutralization
    38 Broad neutralization coverage
    39 HIV
    40 HIV vaccine
    41 PG16
    42 PG9
    43 VRC01
    44 aggregates
    45 analysis
    46 antibodies
    47 antibody-based HIV vaccine
    48 available reveals
    49 breadth
    50 broad coverage
    51 certain combinations
    52 clade
    53 combination
    54 complement
    55 concentration
    56 corresponding donor serum
    57 coverage
    58 design
    59 diversity
    60 donor sera
    61 donors
    62 effective antibody-based HIV vaccine
    63 enormous diversity
    64 envelope glycoprotein gp120
    65 epitopes
    66 eventual design
    67 favorable coverage
    68 full complement
    69 glycoprotein gp120
    70 gp120
    71 human immunodeficiency virus
    72 immunization regimes
    73 immunodeficiency virus
    74 indicators
    75 isolation
    76 low concentrations
    77 monoclonal antibodies
    78 multiple HIV
    79 neutralization
    80 neutralization breadth
    81 neutralization coverage
    82 new monoclonal antibody
    83 new targets
    84 novel epitopes
    85 original prototype HIV
    86 passive immunization regimes
    87 pathogens
    88 positive indicators
    89 potent antibodies
    90 prototype HIV
    91 regime
    92 response
    93 reveals
    94 serum
    95 target
    96 vaccine
    97 vaccine design
    98 variable viral pathogens
    99 viral pathogens
    100 virus
    101 schema:name Broad neutralization coverage of HIV by multiple highly potent antibodies
    102 schema:pagination 466-470
    103 schema:productId N4a451fea04414ca087b5ef677eb0e449
    104 N4e2051008e714fbab220be36b9086b3b
    105 N873b059e5b7e457ca115b8767535125d
    106 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044845665
    107 https://doi.org/10.1038/nature10373
    108 schema:sdDatePublished 2021-12-01T19:24
    109 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    110 schema:sdPublisher N70a9070702b348b5a25aac643c3761b1
    111 schema:url https://doi.org/10.1038/nature10373
    112 sgo:license sg:explorer/license/
    113 sgo:sdDataset articles
    114 rdf:type schema:ScholarlyArticle
    115 N00040b586133416096aadbf69ea731e4 rdf:first sg:person.01035513046.15
    116 rdf:rest Nf6ba3ff652744d5eba2eb360edd17daa
    117 N032d730e6483440b80b10a1654e0098e rdf:first sg:person.0620201437.14
    118 rdf:rest Ne1ce8caa1d29470bb739ef0e7e81c243
    119 N0a1525c790e6456fb71063ff4774d8f1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    120 schema:name Molecular Sequence Data
    121 rdf:type schema:DefinedTerm
    122 N0c05c99457184c5fb3b365fffa9bbe77 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    123 schema:name HIV Infections
    124 rdf:type schema:DefinedTerm
    125 N18038565f028408ca74c4c43c1fdf795 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    126 schema:name Human Immunodeficiency Virus Proteins
    127 rdf:type schema:DefinedTerm
    128 N26d24d20f53d4d53a9ff3c03a8447958 rdf:first sg:person.0623034006.06
    129 rdf:rest N83f796c7239340218eac565835345528
    130 N2d14c9102b0a48a6b7a5c3612f422c80 rdf:first sg:person.01232301406.99
    131 rdf:rest N00040b586133416096aadbf69ea731e4
    132 N2e92e6d75cce4930be56bf832c56a872 rdf:first Nc883de85c7c149118e07a0ba56f60896
    133 rdf:rest N26d24d20f53d4d53a9ff3c03a8447958
    134 N31788b8fdb0e488a8dc1f0fb4d422c27 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    135 schema:name Antibodies, Monoclonal
    136 rdf:type schema:DefinedTerm
    137 N3878766ff1c541f188ca3174ae23971b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    138 schema:name Glycoproteins
    139 rdf:type schema:DefinedTerm
    140 N3fba67be6b1f4c5d8536227012d7316d rdf:first sg:person.01113130537.77
    141 rdf:rest N9609de901b6d44b3bbfa28aae6bde3b8
    142 N42e3c753889c46328868dc834306b1cf rdf:first sg:person.015354421747.51
    143 rdf:rest N957abc4a2a3e4acd82455b5071c97728
    144 N4a451fea04414ca087b5ef677eb0e449 schema:name doi
    145 schema:value 10.1038/nature10373
    146 rdf:type schema:PropertyValue
    147 N4b50f2845bda4328abdbc40bf0cb40a3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    148 schema:name Antibodies, Neutralizing
    149 rdf:type schema:DefinedTerm
    150 N4e2051008e714fbab220be36b9086b3b schema:name pubmed_id
    151 schema:value 21849977
    152 rdf:type schema:PropertyValue
    153 N605b6a4dbe054dfea917216c09240edd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    154 schema:name HIV
    155 rdf:type schema:DefinedTerm
    156 N6403499f3b89410b96177c3085cee5cb rdf:first sg:person.010557764454.41
    157 rdf:rest N751b373a11694cf3940bd94bb7fb5920
    158 N6aae999d2b8142618367f22733c6fab0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    159 schema:name Epitopes
    160 rdf:type schema:DefinedTerm
    161 N70a9070702b348b5a25aac643c3761b1 schema:name Springer Nature - SN SciGraph project
    162 rdf:type schema:Organization
    163 N751b373a11694cf3940bd94bb7fb5920 rdf:first sg:person.01044473444.91
    164 rdf:rest N8a85aa0592ec46d19bcbb00e3f53e073
    165 N7b6dae9099b14c8387121cc3ee614552 rdf:first sg:person.01014667730.93
    166 rdf:rest N42e3c753889c46328868dc834306b1cf
    167 N7ca2c80b553f4d8aa73213c7d8658327 rdf:first sg:person.01132352061.18
    168 rdf:rest Ncf6b42a80dc24efe9cc7eb93b685141a
    169 N83a201b156b34cb191baf776317d906f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    170 schema:name Glycosylation
    171 rdf:type schema:DefinedTerm
    172 N83f796c7239340218eac565835345528 rdf:first sg:person.013704442772.59
    173 rdf:rest Nc58847eaf3234085b9569dd040cb9794
    174 N873b059e5b7e457ca115b8767535125d schema:name dimensions_id
    175 schema:value pub.1044845665
    176 rdf:type schema:PropertyValue
    177 N8a4d24d1adab4897a5a1265ef0f4f281 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    178 schema:name Cell Line
    179 rdf:type schema:DefinedTerm
    180 N8a85aa0592ec46d19bcbb00e3f53e073 rdf:first sg:person.0762674771.14
    181 rdf:rest N2e92e6d75cce4930be56bf832c56a872
    182 N8b897360bca748bdbeef4870f61da36e schema:volumeNumber 477
    183 rdf:type schema:PublicationVolume
    184 N8cfddcb1fcf847c5a2bcdfcbceed47ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    185 schema:name HEK293 Cells
    186 rdf:type schema:DefinedTerm
    187 N8d99ccf520784913b2df832d3b1f9912 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    188 schema:name Humans
    189 rdf:type schema:DefinedTerm
    190 N957abc4a2a3e4acd82455b5071c97728 rdf:first sg:person.01314314746.53
    191 rdf:rest Ne284a58f4be14658b839848d22104234
    192 N9609de901b6d44b3bbfa28aae6bde3b8 rdf:first sg:person.0600752306.32
    193 rdf:rest N7ca2c80b553f4d8aa73213c7d8658327
    194 Na2d78592614b4be0a1f5c819f04d4e08 rdf:first sg:person.01070170150.53
    195 rdf:rest Nf5d18bbac5e14912b842b7ac22c50e2e
    196 Nae04613a0770442ab2606bc7e2f1f127 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    197 schema:name AIDS Vaccines
    198 rdf:type schema:DefinedTerm
    199 Nbb39f983dbae47c0b59f1b53f93a04bd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    200 schema:name Epitope Mapping
    201 rdf:type schema:DefinedTerm
    202 Nc41c6e87fa4a471cb0b8c7c688ac0177 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    203 schema:name HIV Antibodies
    204 rdf:type schema:DefinedTerm
    205 Nc58847eaf3234085b9569dd040cb9794 rdf:first sg:person.01215352065.27
    206 rdf:rest Nfc827c55a7324322904b8b28fdbfaa3c
    207 Ncf6b42a80dc24efe9cc7eb93b685141a rdf:first sg:person.012145621207.41
    208 rdf:rest N6403499f3b89410b96177c3085cee5cb
    209 Ne1ce8caa1d29470bb739ef0e7e81c243 rdf:first sg:person.01115763106.81
    210 rdf:rest N3fba67be6b1f4c5d8536227012d7316d
    211 Ne284a58f4be14658b839848d22104234 rdf:first sg:person.01310030246.94
    212 rdf:rest Na2d78592614b4be0a1f5c819f04d4e08
    213 Ne6d23735271c4c4ea42c9fac6b8190d0 rdf:first sg:person.01342666706.29
    214 rdf:rest N7b6dae9099b14c8387121cc3ee614552
    215 Nf5d18bbac5e14912b842b7ac22c50e2e rdf:first sg:person.01235524034.35
    216 rdf:rest N2d14c9102b0a48a6b7a5c3612f422c80
    217 Nf6ba3ff652744d5eba2eb360edd17daa rdf:first sg:person.01347446637.44
    218 rdf:rest N032d730e6483440b80b10a1654e0098e
    219 Nf734a8a660db47a099ba823fe8e1c3f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    220 schema:name Neutralization Tests
    221 rdf:type schema:DefinedTerm
    222 Nfbf44a9d3b5f4fafb7234edd6bf17ad5 schema:issueNumber 7365
    223 rdf:type schema:PublicationIssue
    224 Nfc827c55a7324322904b8b28fdbfaa3c rdf:first sg:person.01067201057.73
    225 rdf:rest rdf:nil
    226 Nff5701f865fa4230b51a57417c7f486e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    227 schema:name Immune Sera
    228 rdf:type schema:DefinedTerm
    229 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    230 schema:name Medical and Health Sciences
    231 rdf:type schema:DefinedTerm
    232 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
    233 schema:name Immunology
    234 rdf:type schema:DefinedTerm
    235 anzsrc-for:1108 schema:inDefinedTermSet anzsrc-for:
    236 schema:name Medical Microbiology
    237 rdf:type schema:DefinedTerm
    238 sg:grant.2452571 http://pending.schema.org/fundedItem sg:pub.10.1038/nature10373
    239 rdf:type schema:MonetaryGrant
    240 sg:grant.2458801 http://pending.schema.org/fundedItem sg:pub.10.1038/nature10373
    241 rdf:type schema:MonetaryGrant
    242 sg:journal.1018957 schema:issn 0028-0836
    243 1476-4687
    244 schema:name Nature
    245 schema:publisher Springer Nature
    246 rdf:type schema:Periodical
    247 sg:person.01014667730.93 schema:affiliation grid-institutes:grid.461656.6
    248 schema:familyName Huber
    249 schema:givenName Michael
    250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014667730.93
    251 rdf:type schema:Person
    252 sg:person.01035513046.15 schema:affiliation grid-institutes:grid.488352.0
    253 schema:familyName Chan-Hui
    254 schema:givenName Po-Ying
    255 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01035513046.15
    256 rdf:type schema:Person
    257 sg:person.01044473444.91 schema:affiliation grid-institutes:grid.419316.8
    258 schema:familyName Wrin
    259 schema:givenName Terri
    260 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044473444.91
    261 rdf:type schema:Person
    262 sg:person.010557764454.41 schema:affiliation grid-institutes:grid.420368.b
    263 schema:familyName Phogat
    264 schema:givenName Sanjay
    265 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010557764454.41
    266 rdf:type schema:Person
    267 sg:person.01067201057.73 schema:affiliation grid-institutes:grid.420368.b
    268 schema:familyName Poignard
    269 schema:givenName Pascal
    270 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067201057.73
    271 rdf:type schema:Person
    272 sg:person.01070170150.53 schema:affiliation grid-institutes:grid.214007.0
    273 schema:familyName Julien
    274 schema:givenName Jean-Philippe
    275 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070170150.53
    276 rdf:type schema:Person
    277 sg:person.01113130537.77 schema:affiliation grid-institutes:grid.488352.0
    278 schema:familyName Olsen
    279 schema:givenName Ole A.
    280 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01113130537.77
    281 rdf:type schema:Person
    282 sg:person.01115763106.81 schema:affiliation grid-institutes:grid.488352.0
    283 schema:familyName Hammond
    284 schema:givenName Phillip W.
    285 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01115763106.81
    286 rdf:type schema:Person
    287 sg:person.01132352061.18 schema:affiliation grid-institutes:grid.420368.b
    288 schema:familyName Fling
    289 schema:givenName Steven
    290 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132352061.18
    291 rdf:type schema:Person
    292 sg:person.012145621207.41 schema:affiliation grid-institutes:grid.214007.0
    293 schema:familyName Wong
    294 schema:givenName Chi-Huey
    295 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012145621207.41
    296 rdf:type schema:Person
    297 sg:person.01215352065.27 schema:affiliation grid-institutes:grid.461656.6
    298 schema:familyName Burton
    299 schema:givenName Dennis R.
    300 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215352065.27
    301 rdf:type schema:Person
    302 sg:person.01232301406.99 schema:affiliation grid-institutes:grid.214007.0
    303 schema:familyName Ramos
    304 schema:givenName Alejandra
    305 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01232301406.99
    306 rdf:type schema:Person
    307 sg:person.01235524034.35 schema:affiliation grid-institutes:grid.214007.0
    308 schema:familyName Wang
    309 schema:givenName Sheng-Kai
    310 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235524034.35
    311 rdf:type schema:Person
    312 sg:person.01310030246.94 schema:affiliation grid-institutes:grid.214007.0
    313 schema:familyName Pejchal
    314 schema:givenName Robert
    315 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310030246.94
    316 rdf:type schema:Person
    317 sg:person.01314314746.53 schema:affiliation grid-institutes:grid.461656.6
    318 schema:familyName Falkowska
    319 schema:givenName Emilia
    320 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01314314746.53
    321 rdf:type schema:Person
    322 sg:person.01342666706.29 schema:affiliation grid-institutes:grid.214007.0
    323 schema:familyName Walker
    324 schema:givenName Laura M.
    325 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342666706.29
    326 rdf:type schema:Person
    327 sg:person.01347446637.44 schema:affiliation grid-institutes:grid.488352.0
    328 schema:familyName Moyle
    329 schema:givenName Matthew
    330 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01347446637.44
    331 rdf:type schema:Person
    332 sg:person.013704442772.59 schema:affiliation grid-institutes:grid.214007.0
    333 schema:familyName Wilson
    334 schema:givenName Ian A.
    335 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013704442772.59
    336 rdf:type schema:Person
    337 sg:person.015354421747.51 schema:affiliation grid-institutes:grid.461656.6
    338 schema:familyName Doores
    339 schema:givenName Katie J.
    340 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015354421747.51
    341 rdf:type schema:Person
    342 sg:person.0600752306.32 schema:affiliation grid-institutes:grid.419316.8
    343 schema:familyName Phung
    344 schema:givenName Pham
    345 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600752306.32
    346 rdf:type schema:Person
    347 sg:person.0620201437.14 schema:affiliation grid-institutes:grid.488352.0
    348 schema:familyName Mitcham
    349 schema:givenName Jennifer L.
    350 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620201437.14
    351 rdf:type schema:Person
    352 sg:person.0623034006.06 schema:affiliation grid-institutes:grid.420368.b
    353 schema:familyName Koff
    354 schema:givenName Wayne C.
    355 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0623034006.06
    356 rdf:type schema:Person
    357 sg:person.0762674771.14 schema:affiliation grid-institutes:grid.420368.b
    358 schema:familyName Simek
    359 schema:givenName Melissa D.
    360 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0762674771.14
    361 rdf:type schema:Person
    362 sg:pub.10.1038/nature07352 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041549961
    363 https://doi.org/10.1038/nature07352
    364 rdf:type schema:CreativeWork
    365 sg:pub.10.1038/nature09385 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033805072
    366 https://doi.org/10.1038/nature09385
    367 rdf:type schema:CreativeWork
    368 sg:pub.10.1038/ni.1746 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038843818
    369 https://doi.org/10.1038/ni.1746
    370 rdf:type schema:CreativeWork
    371 sg:pub.10.1038/nm.1949 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025533402
    372 https://doi.org/10.1038/nm.1949
    373 rdf:type schema:CreativeWork
    374 sg:pub.10.1038/nm.1974 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021736242
    375 https://doi.org/10.1038/nm.1974
    376 rdf:type schema:CreativeWork
    377 sg:pub.10.1038/nrmicro1819 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031201834
    378 https://doi.org/10.1038/nrmicro1819
    379 rdf:type schema:CreativeWork
    380 grid-institutes:grid.214007.0 schema:alternateName Department of Chemistry, The Scripps Research Institute, La Jolla, California 92037, USA
    381 Department of Immunology and Microbial Science and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California 92037, USA
    382 Department of Molecular Biology, Skaggs Institute for Chemical Biology, and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California 92037, USA
    383 schema:name Department of Chemistry, The Scripps Research Institute, La Jolla, California 92037, USA
    384 Department of Immunology and Microbial Science and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California 92037, USA
    385 Department of Molecular Biology, Skaggs Institute for Chemical Biology, and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California 92037, USA
    386 rdf:type schema:Organization
    387 grid-institutes:grid.419316.8 schema:alternateName Monogram Biosciences, Inc., South San Francisco, California 94080, USA
    388 schema:name Monogram Biosciences, Inc., South San Francisco, California 94080, USA
    389 rdf:type schema:Organization
    390 grid-institutes:grid.420368.b schema:alternateName International AIDS Vaccine Initiative, New York, New York 10038, USA
    391 schema:name Department of Immunology and Microbial Science and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California 92037, USA
    392 International AIDS Vaccine Initiative, New York, New York 10038, USA
    393 rdf:type schema:Organization
    394 grid-institutes:grid.461656.6 schema:alternateName Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts 02129, USA
    395 schema:name Department of Immunology and Microbial Science and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California 92037, USA
    396 Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts 02129, USA
    397 rdf:type schema:Organization
    398 grid-institutes:grid.488352.0 schema:alternateName Theraclone Sciences, Inc., Seattle, Washington 98104, USA
    399 schema:name Theraclone Sciences, Inc., Seattle, Washington 98104, USA
    400 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...